IDH1 and neoplasm: According to the study, MRF can improve glioma diagnosis, prognosis, and treatment planning by providing non-invasive information about the genetic composition of gliomas, identifying IDH mutations, distinguishing between glioblastomas and lower-grade gliomas, and monitoring tumor features.